Skip to main content
. 2022 Jun 27;91(1):58–67. doi: 10.1097/QAI.0000000000003045

TABLE 3.

Number (and Percentage) of Participants With Retention in Care by Subgroup and Measure (N = 799)

Subgroup PHC Measure (% Retained) HRSA HAB Measure (% Retained) 6-Month Visit Gap (% With Gap)
PHC
n (%)
SOC
n (%)
P PHC
n (%)
SOC
n (%)
P PHC
n (%)
SOC
n (%)
P
All participants 257 (65) 247 (61) 0.342 267 (67) 264 (66) 0.654 144 (36) 164 (41) 0.192
Sex
 Male 197 (65) 181 (59) 0.156 204 (67) 192 (63) 0.269 113 (37) 132 (43) 0.160
 Female 60 (64) 66 (69) 0.443 63 (67) 72 (76) 0.200 31 (33) 31 (33) 1.000
Age, yrs
 18–29 33 (57) 41 (58) 1.000 37 (64) 47 (66) 0.853 17 (29) 34 (48) 0.046
 30–39 60 (67) 53 (60) 0.350 58 (65) 60 (68) 0.750 37 (42) 39 (44) 0.762
 40–49 53 (60) 55 (66) 0.430 59 (66) 56 (67) 1.000 36 (40) 28 (34) 0.430
 50–59 71 (68) 76 (64) 0.672 72 (69) 77 (65) 0.670 38 (36) 41 (35) 0.889
 60–81 39 (71) 21 (51) 0.058 40 (73) 23 (56) 0.128 16 (29) 22 (54) 0.020
Race
 White 50 (59) 49 (56) 0.759 48 (56) 54 (61) 0.539 36 (42) 37 (42) 1.000
 Black 200 (67) 192 (64) 0.441 210 (70) 205 (68) 0.596 102 (34) 120 (40) 0.151
 Other 6 (55) 4 (40) 0.670 8 (73) 4 (40) 0.198 4 (36) 6 (60) 0.395
Site
 A 63 (66) 46 (48) 0.013 65 (68) 49 (51) 0.018 36 (38) 53 (55) 0.020
 B 67 (66) 67 (64) 0.883 70 (69) 70 (67) 0.767 32 (32) 38 (37) 0.556
 C 73 (72) 74 (73) 0.875 72 (71) 80 (79) 0.196 30 (29) 31 (31) 0.879
 D 54 (55) 60 (59) 0.568 60 (61) 65 (64) 0.662 46 (46) 42 (42) 0.569
Baseline viral load
 Suppressed 143 (69) 130 (64) 0.253 148 (71) 139 (68) 0.519 66 (32) 76 (37) 0.256
 Unsuppressed 100 (62) 102 (61) 0.821 105 (65) 109 (65) 1.000 64 (40) 73 (43) 0.504
New to care
 Yes 102 (63) 102 (60) 0.735 111 (68) 109 (64) 0.562 63 (39) 68 (40) 0.823
 No 155 (66) 145 (62) 0.386 156 (67) 155 (67) 1.000 81 (35) 96 (41) 0.153
Returned to care
 Yes 48 (75) 47 (73) 1.000 50 (78) 49 (77) 1.000 17 (27) 19 (30) 0.844
 No 209 (63) 200 (59) 0.344 217 (65) 215 (64) 0.688 127 (38) 145 (43) 0.238

P-values are based on Fisher exact tests. For the PHC measure, retention is defined as having at least 1 visit in each 6-month period within 12 months, separated by 2 months or more, postrandomization. For the HRSA HAB measure, retention is defined as having 2 visits separated by ≥90 days postrandomization. For the 6-month visit gap measure, a gap is defined as having ≥189 days elapsed between sequential visits, postrandomization.